the partner 2a & sapien 3 cost-effectiveness studies
Published 6 years ago • 48 plays • Length 5:31Download video MP4
Download video MP3
Similar videos
-
4:21
tct 2017 | partner 2a and sapien 3
-
7:09
tct 2021: partner 3: tavr is cost effective compared with savr for low-risk patients
-
21:16
partner 2a and sapien 3 results: future of tavr
-
6:39
tct 2022: the partner 3 trial: sapien 3 ultra thv for failed aortic bioprosthetic valves | dr garcia
-
7:43
tct 23: 5y outcomes from the partner 3 low-risk trial
-
10:08
aortic valve replacement surgery animation by cal shipley, m.d.
-
14:38
what to expect after tavr
-
3:54
coronary angioplasty (femoral access)
-
3:11
partner 2a | tct 2019
-
3:31
edwards sapien 3 tavr (transfemoral implant procedure animation)
-
41:04
tavr with 26mm sapien 3 ultra valve via right femoral percutaneous approach
-
45:26
valve-in-valve tavr with 26mm sapien-3 - march 2019
-
4:00
transcatheter aortic valve implantation (tavi)
-
45:31
tavr with 23mm sapien-3 - november 2017
-
7:11
acc 2020: updates from the partner 3 trial — dr michael j mack
-
0:19
transcatheter aortic valve implantation (tavi) #science #shorts #anatomy
-
31:10
tavi for severe aortic stenosis using a sapien 3 valve
-
24:34
transcatheter valve replacement (tavr) and savr-update on outcome
-
9:09
europcr 2015: the sapien 3 trials - one year outcomes, with john webb and simon kennon
-
3:47
acc 23: tavr in low-risk aortic stenosis patients: 3-year results from the evolut low risk trial
-
40:04
live case 1 and 2 evolut r viv sapien 3 viv tavr sentinel device